Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 5 studies | 25% ± 7% | |
retinal bipolar neuron | 4 studies | 19% ± 2% | |
retinal rod cell | 4 studies | 29% ± 7% | |
rod bipolar cell | 3 studies | 31% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 4 studies | 22% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 93% | 219.41 | 429 / 459 | 36% | 0.89 | 406 / 1118 |
lung | 99% | 180.81 | 573 / 578 | 20% | 0.47 | 226 / 1155 |
kidney | 96% | 73.12 | 85 / 89 | 21% | 0.44 | 187 / 901 |
thymus | 96% | 103.68 | 630 / 653 | 15% | 0.27 | 88 / 605 |
pancreas | 86% | 50.72 | 281 / 328 | 16% | 0.27 | 29 / 178 |
spleen | 100% | 212.85 | 241 / 241 | 0% | 0 | 0 / 0 |
stomach | 89% | 74.85 | 321 / 359 | 6% | 0.09 | 18 / 286 |
brain | 93% | 132.27 | 2446 / 2642 | 2% | 0.03 | 15 / 705 |
adipose | 93% | 71.57 | 1118 / 1204 | 0% | 0 | 0 / 0 |
intestine | 86% | 181.86 | 828 / 966 | 6% | 0.14 | 34 / 527 |
esophagus | 80% | 41.64 | 1153 / 1445 | 11% | 0.21 | 20 / 183 |
uterus | 78% | 39.51 | 132 / 170 | 13% | 0.37 | 58 / 459 |
peripheral blood | 90% | 90.81 | 834 / 929 | 0% | 0 | 0 / 0 |
prostate | 74% | 43.68 | 182 / 245 | 0% | 0 | 0 / 502 |
skin | 70% | 49.67 | 1266 / 1809 | 4% | 0.05 | 17 / 472 |
bladder | 62% | 29.86 | 13 / 21 | 8% | 0.16 | 42 / 504 |
ovary | 21% | 8.28 | 38 / 180 | 47% | 1.21 | 202 / 430 |
blood vessel | 56% | 26.95 | 754 / 1335 | 0% | 0 | 0 / 0 |
heart | 52% | 19.96 | 447 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 21% | 6.62 | 55 / 258 | 6% | 0.11 | 14 / 230 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.25 | 4 / 29 |
muscle | 13% | 4.18 | 103 / 803 | 0% | 0 | 0 / 0 |
liver | 7% | 2.40 | 16 / 226 | 2% | 0.04 | 9 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.18 | 4 / 45 |
eye | 0% | 0 | 0 / 0 | 8% | 0.81 | 6 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007601 | Biological process | visual perception |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_0050908 | Biological process | detection of light stimulus involved in visual perception |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0043204 | Cellular component | perikaryon |
GO_0001750 | Cellular component | photoreceptor outer segment |
GO_0016020 | Cellular component | membrane |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | CACNA1F |
Protein name | Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4) Calcium voltage-gated channel subunit alpha1 F |
Synonyms | CACNAF1 |
Description | FUNCTION: [Isoform 1]: Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1F gives rise to L-type calcium currents. Long-lasting (L-type) calcium channels belong to the 'high-voltage activated' (HVA) group. They are blocked by dihydropyridines (DHP), phenylalkylamines, and by benzothiazepines. Activates at more negative voltages and does not undergo calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarization. .; FUNCTION: [Isoform 4]: Voltage-dependent L-type calcium channel activates at more hyperpolarized voltages and exhibits a robust calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarizations. .; FUNCTION: [Isoform 6]: Voltage-dependent L-type calcium channel activates at more hyperpolarized voltages and exhibits a robust calcium-dependent inactivation (CDI), due to incoming calcium ions, during depolarizations. . |
Accessions | ENST00000376265.2 [O60840-1] ENST00000376251.5 [O60840-4] ENST00000323022.10 [O60840-2] O60840 H7C549 ENST00000486943.1 |